Alkermes
MA · 40 filings, 2025
What the money shows
Alkermes reported $4M in federal lobbying for 2025 across 40 filings. The filings name 10 lobbying firms, led by LMH Strategic Solutions and BGR Government Affairs. The matched PAC file shows $25,000 to 0 lawmakers. The filing text lists 6 issue areas.
Sources: Senate LDA · FEC
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Medicare/Medicaid · Alcohol and Drug Abuse · Taxation/Internal Revenue Code · Pharmacy · Tariff (miscellaneous tariff bills)
2Through these firms · 10
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5236A bill to amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services…
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5227A bill to amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified t…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
4And its PAC funds these lawmakers · 3
No democrats on file.